Recursion Pharmaceuticals Inc vs Sony Group Corp — how do they compare? Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B), while Sony Group Corp trades at $21.11 (market cap $125.96B). The key difference: Sony Group Corp is far larger — about 82.3× Recursion Pharmaceuticals Inc's market cap, and Sony Group Corp pays a 0.75% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | SONY | |
|---|---|---|
Market Cap | $1.53B | $125.96B |
Sector | Health | Technology |
52-Week High | $6.79 | $30.26 |
52-Week Low | $2.84 | $19.32 |
Enterprise Value | $946.50M | $122.45B |
Dividend Yield | — | 0.75% |
Trailing returns across standard periods
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →Sony Group is a conglomerate with consumer electronics roots, which not only designs, develops, produces, and sells electronic equipment and devices, but also is engaged in content businesses, such as console and mobile games, music, and movies. Sony is a global top company of CMOS image sensors, game consoles, professional broadcasting cameras, and music publishing, and is one of the top players on digital cameras, wireless earphones, recorded music, movies, and so on. Sony's business portfolio is well diversified with six major business segments. The company fully consolidated Sony Financial in September 2020, which provides life and non-life insurance, banking, and other financial services.
Read more on SONY →